Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity
Jonathon Nixon‐Abell(Wellcome/MRC Cambridge Stem Cell Institute), Kirsten Harvey(Medway School of Pharmacy)
Cited by 69
Related Papers
Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER
|Science|2016|489
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling
|Molecular Neurodegeneration|2017|52
Transverse endoplasmic reticulum expansion in hereditary spastic paraplegia corticospinal axons
|Human Molecular Genetics|2022|29